Risk factor
Very high price volatility
Profitability factor
Slightly undervalued vs peers
About
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on
Target Price
The average target price of STAR.NS is 1118 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell